Immunomodulation of cancer: potential use of selectively replicating agents.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

15 citing papers in PubMed.

1. Synergistic targeting strategies for prostate cancer.Nature reviews. Urology · 2025
   Review
2. Clinical translation of immunomodulatory therapeutics.Advanced drug delivery reviews · 2021
   Review
3. Targeted nonviral gene therapy in prostate cancer.International journal of nanomedicine · 2018
   Review
4. Cardiac gene therapy with SERCA2a: from bench to bedside.Journal of molecular and cellular cardiology · 2011
   Review
5. Gene transfer of pro-IL-18 and IL-1beta converting enzyme cDNA induces potent antitumor effects in L1210 cells.Leukemia · 2004
   Article
6. Enhanced antitumor effect of combined replicative adenovirus and nonreplicative adenovirus expressing interleukin-12 in an immunocompetent mouse model.Gene therapy · 2003
   Article
7. Long-lasting gene expression by particle-mediated intramuscular transfection modified with bupivacaine: combinatorial gene therapy with IL-12 and IL-18 cDNA against rat sarcoma at a distant site.Cancer gene therapy · 2003
   Article
8. Inclusion of the herpes simplex thymidine kinase gene in a replicating adenovirus does not augment antitumor efficacy.Gene therapy · 2001
   Article
9. Antitumor immunity induced by irradiated tumor cells producing macrophage colony-stimulating factor.International journal of hematology · 2001
   Article
10. Replication-selective oncolytic adenoviruses: virotherapy aimed at genetic targets in cancer.Oncogene · 2000
    Review
11. Prodrug-activating systems in suicide gene therapy.The Journal of clinical investigation · 2000
    Review
12. Regulatable systems: applications in gene therapy and replicating viruses.The Journal of clinical investigation · 2000
    Review
13. Gene delivery from replication-selective viruses: arming guided missiles in the war against cancer.The Journal of clinical investigation · 2000
    Review
14. A Winning New Combination? Toward Clinical Application in Oncology.Cancer control : journal of the Moffitt Cancer Center
    Review
15. A novel immunization strategy using cytokine/chemokines induces new effective systemic immune responses, and frequent complete regressions of human metastatic melanoma.Oncoimmunology
    Article

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

Authors and funding

2 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as